People with REM sleep behavior disorder, a condition that often precedes Parkinson’s disease, frequently have mitochondrial DNA (mtDNA) damage, a study found. “Patients with REM sleep behavior disorder, both those who subsequently developed Parkinson’s disease and those who did not, had more mitochondrial DNA circulating in the cerebrospinal fluid…
News
Fecal microbiota transplant, a procedure that works to replace a person’s gut bacteria with gut bacteria from a healthy donor, may help ease motor symptoms of Parkinson’s disease, a small clinical trial found. Transplant “offers the advantages of being considered safe based on experience in other indications, and being…
Manifest Technologies has completed initial funding and a partnership with Johnson & Johnson to apply its artificial intelligence (AI)-powered platform toward developing precision treatments for neurological diseases, including Parkinson’s disease, the company announced. The NAIO (Neuroscience and Artificial Intelligence Optimized) platform integrates neuroimaging data from humans and…
A 3D-printed, high-resolution model of the brain has been developed that will offer a promising tool for advancing research into neurodegenerative conditions such as Parkinson’s disease. Dubbed a “brain phantom,” the models were made to mimic the small structural details of nerve cells in the brain, but they aren’t…
NeuroOne has begun a limited U.S. commercial launch of its OneRF Ablation System, a device that can be used for mapping and targeting brain areas with abnormal neuronal activity to treat a range of neurological conditions such as Parkinson’s disease. The company said it’s rolling out the…
The focus of this year’s Parkinson’s Awareness Month, starting today, is on research and a better understanding of the neurodegenerative disorder that affects more than 10 million people globally. World Parkinson’s Day on April 11 is at the center of the observance. Parkinson’s disease can cause a broad array…
Defects in the VPS13C protein, which have been linked to early-onset Parkinson’s disease, disrupt the function of lysosomes, the cell’s recycling compartments, in dopamine-producing nerve cells that are lost in the neurodegenerative condition. Without functional VPS13C, the Rab10 protein can’t respond properly to lysosomal stress, causing dysfunction in the…
New study findings strengthen scientists’ belief that neuroinflammation — an inflammatory response in the central nervous system — is linked to mood disturbance in people with early Parkinson’s disease. Specifically, elevated levels of pro-inflammatory signaling molecules in the cerebrospinal fluid (CSF) were found to be significantly correlated with worse…
Rock Steady Boxing, an exercise program designed for Parkinson’s disease, will participate as a national team in Moving Day, a Walk for Parkinson’s, a fundraiser sponsored by the Parkinson’s Foundation. Between April 6 and June 10, participants will “move for Parkinson’s from anywhere” to raise funds…
After years of delays, medical device company Photopharmics has started a pivotal clinical trial to test its Celeste device, a noninvasive treatment tool that aims to use light to manage the symptoms of Parkinson’s disease. The long-awaited trial has been in the works since 2020, shortly after…
Recent Posts
- Late-onset depression may foreshadow Parkinson’s diagnosis
- Being mad at each other and mad at Parkinson’s disease, too
- Parkinson’s muscle firing patterns different for women than for men
- Breathing CO2 activates brain cleanup signals in new Parkinson’s study
- Guest Voice: DBS surgery transformed my life with early-onset Parkinson’s